Elevance Health, Inc. SEC filings ELV

Elevance Health, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Nov 21, 2013. Its latest annual report, Form 10-K, was filed on Feb 6, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 21, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 21, 2026 (results of operations). The company's fiscal year ends on December 31.

Elevance Health, Inc. SEC filings
Form Description Filed Period
S-3ASR Automatic shelf registration Oct 28, 2026 —
4 Insider transaction Oct 23, 2026 Oct 22, 2026
144 Notice of proposed sale Oct 22, 2026 —
10-Q Quarterly report Oct 21, 2026 Sep 30, 2026
8-K Current report
Results of operations
Oct 21, 2026 Oct 21, 2026
4 Insider transaction Oct 6, 2026 Oct 2, 2026
8-K Current report
Regulation FD disclosure
Sep 10, 2026 Sep 10, 2026
4 Insider transaction Sep 4, 2026 Sep 2, 2026
4 Insider transaction Sep 4, 2026 Sep 2, 2026
4 Insider transaction Jul 17, 2026 Jul 17, 2026
4 Insider transaction Jul 17, 2026 Jul 17, 2026
10-Q Quarterly report Jul 15, 2026 Jun 30, 2026
8-K Current report
Results of operations
Jul 15, 2026 Jul 15, 2026
144 Notice of proposed sale Jul 7, 2026 —
11-K Employee savings plan report Jun 17, 2026 Dec 31, 2025
11-K Employee savings plan report Jun 17, 2026 Dec 31, 2025
4 Insider transaction Jun 15, 2026 Jun 12, 2026
144 Notice of proposed sale Jun 12, 2026 —
4 Insider transaction Jun 12, 2026 Jun 11, 2026
144 Notice of proposed sale Jun 11, 2026 —
8-K Current report
Regulation FD disclosure
Jun 10, 2026 Jun 10, 2026
4 Insider transaction May 20, 2026 May 19, 2026
144 Notice of proposed sale May 19, 2026 —
4 Insider transaction May 15, 2026 May 13, 2026
4 Insider transaction May 15, 2026 May 13, 2026
4 Insider transaction May 15, 2026 May 13, 2026
4 Insider transaction May 15, 2026 May 13, 2026
4 Insider transaction May 15, 2026 May 13, 2026
4 Insider transaction May 15, 2026 May 13, 2026
4 Insider transaction May 15, 2026 May 13, 2026
4 Insider transaction May 15, 2026 May 13, 2026
4 Insider transaction May 15, 2026 May 13, 2026
4 Insider transaction May 15, 2026 May 13, 2026
8-K Current report
Shareholder vote results
May 13, 2026 May 13, 2026
SCHEDULE 13G Ownership over 5% (passive) Apr 29, 2026 —
10-Q Quarterly report Apr 22, 2026 Mar 31, 2026
8-K Current report
Results of operations
Apr 22, 2026 Apr 22, 2026
PX14A6G Filing Apr 7, 2026 —
DEFA14A Additional proxy material Mar 27, 2026 —
DEF 14A Proxy statement Mar 27, 2026 May 13, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 26, 2026 —
4 Insider transaction Mar 23, 2026 Mar 12, 2026
8-K Current report
Regulation FD disclosure
Mar 10, 2026 Mar 10, 2026
4 Insider transaction Mar 9, 2026 Mar 6, 2026
144 Notice of proposed sale Mar 6, 2026 —
4 Insider transaction Mar 6, 2026 Mar 5, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
8-K Current report
Other events
Mar 2, 2026 Mar 2, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Feb 26, 2026 Feb 26, 2026
10-K Annual report Feb 6, 2026 Dec 31, 2025
4 Insider transaction Feb 3, 2026 Feb 2, 2026
4 Insider transaction Feb 3, 2026 Feb 2, 2026
8-K Current report
Results of operations
Jan 28, 2026 Jan 28, 2026
3 Initial insider ownership Jan 14, 2026 Jan 12, 2026
8-K Current report
Officer or director change
Dec 10, 2025 Dec 10, 2025
3/A Form 3/a Nov 21, 2025 Aug 11, 2025
8-K Current report
Regulation FD disclosure
Nov 10, 2025 Nov 10, 2025
10-Q Quarterly report Oct 21, 2025 Sep 30, 2025
8-K Current report
Results of operations
Oct 21, 2025 Oct 21, 2025
4 Insider transaction Oct 3, 2025 Oct 2, 2025
8-K Current report
Other events
Sep 15, 2025 Sep 8, 2025
424B3 Prospectus Sep 9, 2025 —
FWP Free writing prospectus Sep 8, 2025 —
424B3 Prospectus Sep 8, 2025 —
4 Insider transaction Sep 5, 2025 Sep 3, 2025
3 Initial insider ownership Sep 5, 2025 Aug 11, 2025
3 Initial insider ownership Sep 5, 2025 Aug 11, 2025
4 Insider transaction Sep 4, 2025 Sep 2, 2025
4 Insider transaction Sep 4, 2025 Sep 2, 2025
8-K Current report
Regulation FD disclosure
Sep 4, 2025 Sep 4, 2025
4 Insider transaction Aug 21, 2025 Aug 19, 2025
4 Insider transaction Aug 5, 2025 Aug 1, 2025
3 Initial insider ownership Aug 1, 2025 Aug 1, 2025
8-K Current report
Officer or director change
Jul 28, 2025 Jul 28, 2025
4 Insider transaction Jul 18, 2025 Jul 18, 2025
10-Q Quarterly report Jul 17, 2025 Jun 30, 2025
8-K Current report
Results of operations
Jul 17, 2025 Jul 17, 2025
11-K Employee savings plan report Jun 24, 2025 Dec 31, 2024
11-K Employee savings plan report Jun 24, 2025 Dec 31, 2024
8-K Current report
Regulation FD disclosure
May 28, 2025 May 28, 2025
4 Insider transaction May 16, 2025 May 14, 2025
4 Insider transaction May 16, 2025 May 14, 2025
4 Insider transaction May 16, 2025 May 14, 2025
4 Insider transaction May 16, 2025 May 14, 2025
4 Insider transaction May 16, 2025 May 14, 2025
4 Insider transaction May 16, 2025 May 14, 2025
4 Insider transaction May 16, 2025 May 14, 2025
4 Insider transaction May 16, 2025 May 14, 2025
4 Insider transaction May 16, 2025 May 14, 2025
8-K Current report
Shareholder vote results
May 14, 2025 May 14, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 7, 2025 —
4 Insider transaction Apr 25, 2025 Apr 24, 2025
144 Notice of proposed sale Apr 24, 2025 —
10-Q Quarterly report Apr 22, 2025 Mar 31, 2025
8-K Current report
Results of operations
Apr 22, 2025 Apr 22, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Apr 17, 2025 Apr 17, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 17, 2025 —
PX14A6G Filing Apr 14, 2025 —
DEFA14A Additional proxy material Mar 28, 2025 —
DEFA14A Additional proxy material Mar 28, 2025 —
DEF 14A Proxy statement Mar 28, 2025 May 14, 2025
4 Insider transaction Mar 11, 2025 Mar 10, 2025
8-K Current report
Regulation FD disclosure
Mar 10, 2025 Mar 10, 2025
144 Notice of proposed sale Mar 10, 2025 —
4 Insider transaction Mar 5, 2025 Mar 3, 2025
144 Notice of proposed sale Mar 5, 2025 —
4 Insider transaction Mar 5, 2025 Mar 3, 2025
4 Insider transaction Mar 5, 2025 Mar 3, 2025
4 Insider transaction Mar 5, 2025 Mar 3, 2025
4 Insider transaction Mar 5, 2025 Mar 3, 2025
4 Insider transaction Mar 5, 2025 Mar 3, 2025
4 Insider transaction Mar 5, 2025 Mar 3, 2025
10-K Annual report Feb 20, 2025 Dec 31, 2024
8-K Current report
Results of operations
Jan 23, 2025 Jan 23, 2025
4 Insider transaction Jan 7, 2025 Dec 1, 2023
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
4 Insider transaction Nov 5, 2024 Nov 1, 2024
4 Insider transaction Nov 5, 2024 Nov 1, 2024
8-K Current report
Other events
Oct 31, 2024 Oct 22, 2024
424B3 Prospectus Oct 23, 2024 —
FWP Free writing prospectus Oct 22, 2024 —
424B3 Prospectus Oct 22, 2024 —
4 Insider transaction Oct 18, 2024 Oct 18, 2024
144 Notice of proposed sale Oct 18, 2024 —
10-Q Quarterly report Oct 17, 2024 Sep 30, 2024
8-K Current report
Results of operations
Oct 17, 2024 Oct 17, 2024
4 Insider transaction Oct 4, 2024 Oct 2, 2024
4 Insider transaction Aug 6, 2024 Aug 5, 2024
144 Notice of proposed sale Aug 5, 2024 —
4 Insider transaction Jul 23, 2024 Jul 22, 2024
4 Insider transaction Jul 22, 2024 Jul 19, 2024
144 Notice of proposed sale Jul 22, 2024 —
144 Notice of proposed sale Jul 19, 2024 —
10-Q Quarterly report Jul 17, 2024 Jun 30, 2024
8-K Current report
Results of operations
Jul 17, 2024 Jul 17, 2024
11-K Employee savings plan report Jun 20, 2024 Dec 31, 2023
8-K Current report
Regulation FD disclosure
Jun 12, 2024 Jun 12, 2024
8-K Current report
Other events
May 30, 2024 May 20, 2024
424B3 Prospectus May 21, 2024 —
FWP Free writing prospectus May 20, 2024 —
424B3 Prospectus May 20, 2024 —
4 Insider transaction May 17, 2024 May 15, 2024
4 Insider transaction May 17, 2024 May 15, 2024
4 Insider transaction May 17, 2024 May 15, 2024
4 Insider transaction May 17, 2024 May 15, 2024
4 Insider transaction May 17, 2024 May 15, 2024
4 Insider transaction May 17, 2024 May 15, 2024
4 Insider transaction May 17, 2024 May 15, 2024
4 Insider transaction May 17, 2024 May 15, 2024
4 Insider transaction May 17, 2024 May 15, 2024
4 Insider transaction May 17, 2024 May 15, 2024
8-K Current report
Shareholder vote results
May 15, 2024 May 15, 2024
4 Insider transaction Apr 25, 2024 Apr 23, 2024
144 Notice of proposed sale Apr 23, 2024 —
DEFA14A Additional proxy material Apr 22, 2024 —
10-Q Quarterly report Apr 18, 2024 Mar 31, 2024
8-K Current report
Results of operations
Apr 18, 2024 Apr 18, 2024
DEFA14A Additional proxy material Mar 29, 2024 —
DEF 14A Proxy statement Mar 29, 2024 May 15, 2024
4 Insider transaction Mar 12, 2024 Mar 8, 2024
4 Insider transaction Mar 8, 2024 Mar 6, 2024
144 Notice of proposed sale Mar 8, 2024 —
144 Notice of proposed sale Mar 6, 2024 —
4 Insider transaction Mar 5, 2024 Mar 1, 2024
4 Insider transaction Mar 5, 2024 Mar 1, 2024
4 Insider transaction Mar 5, 2024 Mar 1, 2024
4 Insider transaction Mar 5, 2024 Mar 1, 2024
4 Insider transaction Mar 5, 2024 Mar 1, 2024
4 Insider transaction Mar 5, 2024 Mar 1, 2024
4 Insider transaction Mar 5, 2024 Mar 1, 2024
4 Insider transaction Mar 5, 2024 Mar 1, 2024
144 Notice of proposed sale Mar 4, 2024 —
8-K Current report
Regulation FD disclosure
Mar 4, 2024 Mar 4, 2024
S-8 Employee stock plan registration Feb 23, 2024 —
10-K Annual report Feb 21, 2024 Dec 31, 2023
SC 13G Ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 12, 2024 —
4 Insider transaction Feb 9, 2024 Feb 7, 2024
3 Initial insider ownership Feb 9, 2024 Feb 9, 2024
144 Notice of proposed sale Feb 7, 2024 —
8-K Current report
Other events
Jan 25, 2024 Jan 23, 2024
8-K Current report
Results of operations
Jan 24, 2024 Jan 24, 2024
4 Insider transaction Jan 5, 2024 Jan 3, 2024
4 Insider transaction Dec 15, 2023 Dec 14, 2023
144 Notice of proposed sale Dec 14, 2023 —
4 Insider transaction Dec 5, 2023 Dec 1, 2023
4 Insider transaction Dec 1, 2023 Nov 30, 2023
144 Notice of proposed sale Nov 30, 2023 —
4 Insider transaction Nov 3, 2023 Nov 1, 2023
4 Insider transaction Nov 3, 2023 Nov 1, 2023
S-3ASR Automatic shelf registration Nov 1, 2023 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Hospital & Medical Service Plans (SIC 6324)
Listed as
ELV (NYSE)
Fiscal year ends
December 31
Incorporated in
IN
Headquarters
Indianapolis, IN
SEC filer status
Large accelerated filer
SEC CIK
1156039
Former names
Anthem, Inc. (until Jun 24, 2022); WELLPOINT, INC (until Nov 12, 2014); WELLPOINT INC (until Dec 21, 2009); ANTHEM INC (until Nov 30, 2004)

Other Hospital & Medical Service Plans companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.